IBDEI0JW ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8951,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,8951,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,8952,0)
 ;;=R76.11^^39^403^1
 ;;^UTILITY(U,$J,358.3,8952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8952,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,8952,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,8952,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,8953,0)
 ;;=Z21.^^39^403^33
 ;;^UTILITY(U,$J,358.3,8953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8953,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,8953,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,8953,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,8954,0)
 ;;=B37.0^^39^403^18
 ;;^UTILITY(U,$J,358.3,8954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8954,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,8954,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,8954,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,8955,0)
 ;;=B97.10^^39^403^25
 ;;^UTILITY(U,$J,358.3,8955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8955,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,8955,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,8955,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,8956,0)
 ;;=R50.82^^39^403^27
 ;;^UTILITY(U,$J,358.3,8956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8956,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,8956,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,8956,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,8957,0)
 ;;=R50.83^^39^403^29
 ;;^UTILITY(U,$J,358.3,8957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8957,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,8957,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,8957,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,8958,0)
 ;;=R50.84^^39^403^28
 ;;^UTILITY(U,$J,358.3,8958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8958,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,8958,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,8958,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,8959,0)
 ;;=B02.23^^39^403^74
 ;;^UTILITY(U,$J,358.3,8959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8959,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,8959,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,8959,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,8960,0)
 ;;=B02.22^^39^403^75
 ;;^UTILITY(U,$J,358.3,8960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8960,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,8960,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,8960,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,8961,0)
 ;;=J03.91^^39^403^87
 ;;^UTILITY(U,$J,358.3,8961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8961,1,3,0)
 ;;=3^Tonsillitis,Acute Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,8961,1,4,0)
 ;;=4^J03.91
 ;;^UTILITY(U,$J,358.3,8961,2)
 ;;=^5008136
 ;;^UTILITY(U,$J,358.3,8962,0)
 ;;=U07.1^^39^403^16
 ;;^UTILITY(U,$J,358.3,8962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8962,1,3,0)
 ;;=3^COVID-19
 ;;^UTILITY(U,$J,358.3,8962,1,4,0)
 ;;=4^U07.1
 ;;^UTILITY(U,$J,358.3,8962,2)
 ;;=^5159070
 ;;^UTILITY(U,$J,358.3,8963,0)
 ;;=A84.81^^39^403^76
 ;;^UTILITY(U,$J,358.3,8963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8963,1,3,0)
 ;;=3^Powassan Virus Disease
 ;;^UTILITY(U,$J,358.3,8963,1,4,0)
 ;;=4^A84.81
 ;;^UTILITY(U,$J,358.3,8963,2)
 ;;=^5159071
 ;;^UTILITY(U,$J,358.3,8964,0)
 ;;=A84.89^^39^403^85
 ;;^UTILITY(U,$J,358.3,8964,1,0)
 ;;=^358.31IA^4^2
